Business Standard

Thursday, January 09, 2025 | 05:57 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment

Image

Capital Market

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/ 1 mg per gram, the generic version of Nystatin and Trimacinolone Acetonide Ointment USP, 100,000 units/ 1mg per gram of Taro.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 24 2016 | 10:46 AM IST

Explore News